Niranjan Kanesa-Thasan

Title: Innovations by Niranjan Kanesa-Thasan

Introduction

Niranjan Kanesa-Thasan is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines and diagnostic assays for dengue virus.

Latest Patents

Niranjan holds 2 patents that showcase his innovative work. His latest patents include a multivalent dengue virus vaccine, which provides vaccine compositions of attenuated dengue virus. This invention is produced by serial passage in PDK cells and aims to stimulate the immune system to induce protection against all four dengue virus serotypes. Another significant patent is for a flavivirus detection and quantification assay. This assay utilizes fluorescent DNA probes specific to the conserved terminal 3′-noncoding region of the dengue virus, allowing for the detection of low levels of the virus from clinical specimens.

Career Highlights

Throughout his career, Niranjan has worked with the US Government, specifically represented by the Secretary of the Army and the U.S. Army Medical Research and Materiel Command. His work has been instrumental in advancing the understanding and treatment of dengue virus infections.

Collaborations

Niranjan has collaborated with notable professionals in his field, including Kenneth H Eckels and Joseph B Putnak. Their combined expertise has contributed to the success of his research and innovations.

Conclusion

Niranjan Kanesa-Thasan's contributions to vaccine development and diagnostic methods for dengue virus highlight his role as a significant inventor in the medical research community. His work continues to impact public health positively.